Lessee, Operating Lease, Liability, to be Paid, Year Two of Cordyceps Sunshine Biotech Holdings Co., Ltd. from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary: Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD history and change rate from 31 Dec 2022 to 31 Dec 2024.
Cordyceps Sunshine Biotech Holdings Co., Ltd. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Dec 2024 was $12,687, a 87% decline year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

Cordyceps Sunshine Biotech Holdings Co., Ltd. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$12,687	-$82,276	-87%	31 Dec 2024	20-F	13 Jun 2025	2024	FY
Q4 2023	$94,963	+$31,964	+51%	31 Dec 2023	20-F/A	23 Sep 2025	2023	FY
Q3 2023	$85,732			30 Sep 2023	6-K	13 Nov 2023	2023	Q3
Q4 2022	$62,999			31 Dec 2022	20-F	15 May 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.